https://uat.neogen.segnoeforma.cloud/en/news-and-communications/neopharmed-gentili-supports-sport-as-a-tool-for-inclusion-and-freedom/2025-12-10T13:49:59+00:00https://uat.neogen.segnoeforma.cloud/en/news-and-communications/neopharmed-gentili-acquires-lormetazepam-product/2025-11-19T09:11:04+00:00https://uat.neogen.segnoeforma.cloud/en/news-and-communications/italian-pharma-firms-driving-force-of-the-national-economy/2025-11-19T09:17:07+00:00https://uat.neogen.segnoeforma.cloud/en/news-and-communications/neopharmed-gentili-announces-ceo-transition/2025-11-19T09:03:16+00:00https://uat.neogen.segnoeforma.cloud/en/news-and-communications/a-responsible-and-solid-commitment-to-our-people-the-environment-and-the-community/2025-11-19T09:12:20+00:00https://uat.neogen.segnoeforma.cloud/en/news-and-communications/ardian-acquires-majority-stake-in-neopharmed-gentili/2025-11-19T09:01:34+00:00https://uat.neogen.segnoeforma.cloud/en/news-and-communications/neopharmed-gentili-acquires-mdm/2025-11-19T08:42:01+00:00https://uat.neogen.segnoeforma.cloud/en/news-and-communications/neopharmed-gentili-acquires-the-european-orladeyo-business-from-biocryst-pharmaceuticals/2025-11-19T08:59:25+00:00https://uat.neogen.segnoeforma.cloud/en/news-and-communications/neopharmed-gentili-s-p-a-places-an-amount-of-e100-million-of-senior-secured-notes/2025-11-19T09:47:23+00:00https://uat.neogen.segnoeforma.cloud/en/news-and-communications/neopharmed-gentili-acquires-the-italian-valeas/2025-11-19T08:57:09+00:00https://uat.neogen.segnoeforma.cloud/en/news-and-communications/nb-renaissance-new-partner-for-neopharmed-gentili-and-ardian/2025-12-01T10:15:23+00:00https://uat.neogen.segnoeforma.cloud/en/news-and-communications/concerts-of-hope-a-celebration-of-music-inclusion-and-togetherness/2025-11-19T08:49:43+00:00https://uat.neogen.segnoeforma.cloud/en/news-and-communications/neopharmed-gentili-s-p-a-places-e750-million-bonds/2025-11-19T08:49:00+00:00https://uat.neogen.segnoeforma.cloud/en/news-and-communications/neopharmed-gentili-acquires-metoclopramide-product/2025-11-26T08:39:58+00:00https://uat.neogen.segnoeforma.cloud/en/news-and-communications/neopharmed-gentili-donates-50000-euros-for-the-earthquake-in-turkey/2025-11-20T15:08:01+00:00https://uat.neogen.segnoeforma.cloud/en/news-and-communications/young-athletes-shine-at-palaluiss-sports-afternoon/2025-11-19T08:44:40+00:00https://uat.neogen.segnoeforma.cloud/en/news-and-communications/hypnosis-a-neopharmed-gentili-s-event-on-insomnia/2025-12-18T11:01:22+00:00https://uat.neogen.segnoeforma.cloud/en/news-and-communications/neopharmed-gentili-donates-medicines-for-ukraine/2025-11-21T15:03:05+00:00https://uat.neogen.segnoeforma.cloud/en/news-and-communications/neopharmed-gentili-alongside-fondazione-libellula/2025-11-24T09:22:24+00:00https://uat.neogen.segnoeforma.cloud/en/news-and-communications/neopharmed-gentili-completes-acquisition-of-european-orladeyo-business-from-biocryst-pharmaceuticals/2025-12-10T13:50:33+00:00https://uat.neogen.segnoeforma.cloud/en/news-and-communications/erectile-dysfunction-raising-awareness/2025-11-24T16:20:29+00:00https://uat.neogen.segnoeforma.cloud/en/news-and-communications/sports-and-disability-a-winning-combination/2025-11-26T08:37:44+00:00https://uat.neogen.segnoeforma.cloud/en/news-and-communications/eric-falcand-is-the-new-ceo-of-neopharmed-gentili/2025-11-26T11:16:55+00:00https://uat.neogen.segnoeforma.cloud/en/news-and-communications/new-licensing-agreement-with-lupin-limited-for-the-commercialization-and-promotion-of-plasil-in-brazil-and-the-philippines/2025-12-18T10:01:04+00:00https://uat.neogen.segnoeforma.cloud/en/news-and-communications/neopharmed-gentilis-scientific-event-in-milan-experts-shine-a-spotlight-on-leg-health/2026-03-26T09:38:33+00:00https://uat.neogen.segnoeforma.cloud/en/news-and-communications/neopharmed-gentili-acquires-exclusive-rights-to-navenibart-in-europe-from-biocryst-pharmaceuticals/2026-05-05T09:05:19+00:00https://uat.neogen.segnoeforma.cloud/en/news-and-communications/haello-were-heare-the-event-to-raise-awareness-of-hereditary-angioedema/2026-06-05T09:43:28+00:00https://uat.neogen.segnoeforma.cloud/en/news-and-communications/chmp-issues-a-positive-opinion-on-the-paediatric-extension-of-orladeyo-berotralstat-for-the-treatment-of-hereditary-angioedema/2026-06-26T10:20:41+00:00